- Home
- JSPR vs OPTH Comparison
JSPR vs OPTH Comparison
Compare JSPR & OPTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | JSPR | OPTH |
|---|---|---|
| Founded | 2018 | N/A |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 26.3M | 28.9M |
| IPO Year | 2019 | 2024 |
Fundamental Metrics
Financial Performance| Metric | JSPR | OPTH |
|---|---|---|
| Price | $0.68 | $4.42 |
| Analyst Decision | Buy | |
| Analyst Count | 11 | 0 |
| Target Price | ★ $15.50 | N/A |
| AVG Volume (30 Days) | ★ 604.9K | 36.9K |
| Earning Date | 05-12-2026 | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 19.22 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.32 | $4.00 |
| 52 Week High | $2.69 | $5.45 |
Technical Indicators
Market Signals| Indicator | JSPR | OPTH |
|---|---|---|
| Relative Strength Index (RSI) | 49.62 | 37.46 |
| Support Level | $0.64 | $4.05 |
| Resistance Level | $1.01 | $5.07 |
| Average True Range (ATR) | 0.05 | 0.25 |
| MACD | -0.01 | -0.06 |
| Stochastic Oscillator | 66.21 | 30.73 |
Price Performance
Historical ComparisonAbout JSPR Jasper Therapeutics Inc.
Jasper Therapeutics Inc is a clinical-stage biotechnology company focused on developing therapeutics targeting mast cell driven diseases such as Chronic Spontaneous Urticaria (CSU), Chronic Inducible Urticaria (CIndU) and asthma. The company's lead product candidate, briquilimab, is a monoclonal antibody designed to block stem cell factor (SCF) from binding to and signaling through the CD117 (KIT) receptor on mast and stem cells. The company has a single operating and reportable segment, which is the research and development of therapeutic products in the fields of chronic urticaria and asthma.
About OPTH Optimi Health Corp. Common Shares
Optimi Health Corp operates in developing a vertically integrated Canadian functional mushroom brand that focuses on the health and wellness sector. The company has one reportable operating segment being that of the farming, processing, and distribution of raw mushroom biomass. It also intends to cultivate, extract, process, and distribute strains of fungi products at its facilities located in Princeton, British Columbia.